Advertisement

Laparoscopic gastric banding resolves the metabolic syndrome and improves lipid profile over five years in obese patients with body mass index 30–40 kg/m2

      Highlights

      • Gastric banding resolves the metabolic syndrome over five years in nonmorbidly obese patients.
      • Gastric banding produces increased HDL-C and HDL particle concentrations.
      • Gastric banding does not result in changes in LDL-C, LDL particle size or particle number.
      • Changes in HDL-C and HDL particles did not correlate with weight loss or waist circumference.

      Abstract

      Background

      Obesity, metabolic syndrome (MS) and dyslipidemia are independent risk factors for cardiovascular disease. Bariatric surgery is increasingly recognized as an effective intervention for improving each of these risk factors. There are sparse data on the long-term durability of metabolic changes associated with bariatric surgery, in particular with laparoscopic gastric banding (LGB). Our objective was to evaluate the durability of metabolic changes associated with LGB in nonmorbid obesity.

      Methods

      Fifty obese patients (BMI 30–40) with ≥1 obesity-related comorbidity were prospectively followed for five years. At follow-up, subjects underwent fasting blood measures, including lipid NMR spectroscopy and standard lipid profile.

      Results

      Forty-seven patients (45 female, mean age 43.8 years) completed four years follow-up (46 completed five years). Baseline BMI was 35.1 ± 2.6. Subjects exhibited mean weight loss of 22.3 ± 7.9 kg (22.9 ± 7.4%) at year one and maintained this (19.8 ± 10.2%) over five years. At baseline, 43% (20/47) of subjects met criteria for MS. This was reduced to 15% (7/47) at year one and remained reduced over five years (13%, 6/46) (p < 0.001). There were reductions in triglycerides (p < 0.001) and increases in HDL cholesterol (HDL-C, p < 0.001) and HDL particle concentration (p = 0.02), with a trend toward increased HDL particle size (p = 0.06) at year five. Changes in triglycerides and HDL-C were more prominent in patients with MS at baseline, but unassociated with weight loss or waist circumference. Changes in HDL particle size and concentration were not associated with MS status, weight loss, waist circumference, or statin use.

      Conclusions

      LGB produces significant weight loss, resolution of MS and changes in lipid profile suggestive of beneficial HDL remodeling. These changes persist five years following LGB.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Grundy S.
        • Brewer Jr., H.
        • Cleeman J.
        • Smith Jr., S.
        • Lenfant C.
        • American Heart Association; National Heart, Lung, and Blood Institute
        Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition.
        Circulation. 2004; 109: 433-438
        • Cannon C.
        • Kumar A.
        Treatment of overweight and obesity: lifestyle, pharmacologic, and surgical options.
        Clin Cornerstone. 2009; 9: 55-68
        • Clifton P.
        Bariatric surgery: effects on the metabolic complications of obesity.
        Curr Atheroscler Rep. 2012; 14: 95-100https://doi.org/10.1007/s11883-012-0231-6
        • Buchwald H.
        • Estock R.
        • Fahrbach K.
        • Banel D.
        • Jensen M.
        • Pories W.J.
        • et al.
        Weight and type 2 diabetes after bariatricsurgery: systematic review and metaanalysis.
        Am J Med. 2009; 122: 248-256https://doi.org/10.1016/j.amjmed.2008.09.041
        • Mingrone G.
        • Panuzzi S.
        • De Gaetano A.
        • Guidone C.
        • Iaconelli A.
        • Leccesi L.
        • et al.
        Bariatric surgery versus conventional medical therapy for type 2 diabetes.
        New Engl J Med. 2012; 366: 1577-1585https://doi.org/10.1056/NEJMoa1200111
        • Ikramuddin S.
        • Korner J.
        • Lee W.
        • Connett J.
        • Inabnet W.
        • Billington C.
        • et al.
        Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the diabetes surgery study randomized clinical trial.
        JAMA. 2013; 309: 2240-2249https://doi.org/10.1001/jama.2013.5835
        • Sjöström L.
        • Lindroos A.
        • Peltonen M.
        • Torgerson J.
        • Bouchard C.
        • Carlsson B.
        • et al.
        • Swedish Obese Subjects Study Scientific Group
        Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.
        New Engl J Med. 2004; 351: 2683-2693
        • Dixon J.
        • Murphy D.
        • Segel J.
        • Finkelstein E.A.
        Impact of laparoscopic adjustable gastric banding on type 2 diabetes.
        Obes Rev. 2012; 13: 57-67https://doi.org/10.1111/j.1467-789X.2011.00928.x
        • Poirier P.
        • Cornier M.
        • Mazzone T.
        • Stiles S.
        • Cummings S.
        • Klein S.
        • et al.
        • American Heart Association obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism
        Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association.
        Circulation. 2011; 123: 1683-1701https://doi.org/10.1161/CIR.0b013e3182149099
        • Ponce J.
        • Haynes B.
        • Paynter S.
        • Fromm R.
        • Lindsey B.
        • Shafer A.
        • et al.
        Effect of lap-band-induced weight loss on type 2 diabetes mellitus and hypertension.
        Obes Surg. 2004; 14: 1335-1342
        • Sultan S.
        • Parikh M.
        • Youn H.
        • Kurian M.
        • Fielding G.
        • Ren C.
        Early U.S. outcomes after laparoscopic adjustable gastric banding in patients with a body mass index less than 35 kg/m2.
        Surg Endosc. 2009; 23: 1569-1573https://doi.org/10.1007/s00464-009-0341-6
        • Singhal R.
        • Kitchen M.
        • Bridgwater S.
        • Super P.
        Metabolic outcomes of obese diabetic patients following laparoscopic adjustable gastric banding.
        Obes Surg. 2008; 18: 1400-1405https://doi.org/10.1007/s11695-008-9500-4
        • Hall T.
        • Pellen M.
        • Sedman P.
        • Jain P.
        Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity.
        Obes Surg. 2010; 20: 1245-1250https://doi.org/10.1007/s11695-010-0198-8
        • O'Brien P.
        • Dixon J.
        • Laurie C.
        • Skinner S.
        • Proietto J.
        • McNeil J.
        • et al.
        Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial.
        Ann Intern Med. 2006; 144: 625-633
        • Maggard-Gibbons M.
        • Maglione M.
        • Livhits M.
        • Ewing B.
        • Maher A.
        • Hu J.
        • et al.
        Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes: a systematic review.
        JAMA. 2013; 309: 2250-2261https://doi.org/10.1001/jama.2013.4851
        • Dixon J.
        • O'Brien P.
        • Playfair J.
        • Chapman L.
        • Schachter L.
        • Skinner S.
        • et al.
        Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial.
        JAMA. 2008; 299: 316-323https://doi.org/10.1001/jama.299.3.316
        • Kip K.
        • Marroquin O.
        • Kelley D.
        • Johnson B.
        • Kelsey S.
        • Shaw L.
        • et al.
        Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the women's ischemia syndrome evaluation (WISE) study.
        Circulation. 2004; 109: 706-713
        • St-Pierre A.
        • Cantin B.
        • Mauriège P.
        • Bergeron J.
        • Dagenais G.
        • Després J.
        • et al.
        Insulin resistance syndrome, body mass index and the risk of ischemic heart disease.
        CMAJ. 2005; 172: 1301-1305
        • Pontiroli A.
        • Laneri M.
        • Veronelli A.
        • Frigè F.
        • Micheletto G.
        • Folli F.
        • et al.
        Biliary pancreatic diversion and laparoscopic adjustable gastric banding in morbid obesity: their long-term effects on metabolic syndrome and on cardiovascular parameters.
        Cardiovasc Diabetol. 2009; 8: 37https://doi.org/10.1186/1475-2840-8-37
        • Peeters A.
        • O'Brien P.
        • Laurie C.
        • Anderson M.
        • Wolfe R.
        • Flum D.
        • et al.
        Substantial intentional weight loss and mortality in the severely obese.
        Ann Surg. 2007; 246: 1028-1033
        • Busetto L.
        • Mirabelli D.
        • Petroni M.L.
        • Mazza M.
        • Favretti F.
        • Segato G.
        • et al.
        Comparative long-term mortality after laparoscopic adjustable gastric banding versus nonsurgical controls.
        Surg Obes Relat Dis. 2007; 3: 496-502
        • Parikh M.
        • Ayoung-Chee P.
        • Romanos E.
        • Lewis N.
        • Pachter H.
        • Fielding G.
        • et al.
        Comparison of rates of resolution of diabetes mellitus after gastric banding, gastric bypass, and biliopancreatic diversion.
        J Am Coll Surg. 2007; 205: 631-635
        • Hinojosa M.
        • Varela J.
        • Smith B.
        • Che F.
        • Nguyen N.
        Resolution of systemic hypertension after laparoscopic gastric bypass.
        J Gastrointest Surg. 2009; 13: 793-797https://doi.org/10.1007/s11605-008-0759-5
        • Pontiroli A.
        • Pizzocri P.
        • Librenti M.
        • Vedani P.
        • Marchi M.
        • Cucchi E.
        • et al.
        Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study.
        J Clin Endocrinol Metab. 2002; 87: 3555-3561
        • Asztalos B.
        • Swarbrick M.
        • Schaefer E.
        • Dallal G.
        • Horvath K.
        • Ai M.
        • et al.
        Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women.
        J Lipid Res. 2010; 51: 2405-2412https://doi.org/10.1194/jlr.P900015
        • Laimer M.
        • Engl J.
        • Tschoner A.
        • Kaser S.
        • Ritsch A.
        • Tatarczyk T.
        • et al.
        Effects of weight loss on lipid transfer proteins in morbidly obese women.
        Lipids. 2009; 44: 1125-1130https://doi.org/10.1007/s11745-009-3349-8
        • Aron-Wisnewsky J.
        • Julia Z.
        • Poitou C.
        • Bouillot J.
        • Basdevant A.
        • Chapman M.
        • et al.
        Effect of bariatric surgery-induced weight loss on SR-BI-, ABCG1-, and ABCA1-mediated cellular cholesterol efflux in obese women.
        J Clin Endocrinol Metab. 2011; 96: 1151-1159https://doi.org/10.1210/jc.2010-2378
        • Otvos J.D.
        • Collins D.
        • Freedman D.S.
        • Shalaurova I.
        • Schaefer E.J.
        • McNamara J.R.
        • et al.
        Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the veterans affairs high-density lipoprotein intervention trial.
        Circulation. 2006; 113: 1556-1563
        • Williams P.T.
        • Feldman D.E.
        Prospective study of coronary heart disease vs. HDL2, HDL3, and other lipoproteins in Gofman's livermore Cohort.
        Atherosclerosis. 2011; 214: 196-202https://doi.org/10.1016/j.atherosclerosis.2010.10.024
        • Salonen J.T.
        • Salonen R.
        • Seppänen K.
        • Rauramaa R.
        • Tuomilehto J.
        HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men.
        Circulation. 1991; 84: 129-139
        • El Harchaoui K.
        • Arsenault B.J.
        • Franssen R.
        • Després J.P.
        • Hovingh G.K.
        • Stroes E.S.
        • et al.
        High-density lipoprotein particle size and concentration and coronary risk.
        Ann Intern Med. 2009; 150: 84-93
        • To V.
        • Huttl T.
        • Lang R.
        • Piotrowski K.
        • Parhofer K.
        Changes in body weight, glucose homeostasis, lipid profiles, and metabolic syndrome after restrictive bariatric surgery.
        Exp Clin Endocrinol Diabetes. 2012; 120: 547-552https://doi.org/10.1055/s-0032-1323738
        • Benaiges D.
        • Flores-Le-Roux J.
        • Pedro-Botet J.
        • Ramon J.M.
        • Parri A.
        • Villatoro M.
        • et al.
        • Obemar Group
        Impact of restrictive (sleeve gastrectomy) vs hybrid bariatric surgery (Roux-en-Y gastric bypass) on lipid profile.
        Obes Surg. 2012; 22: 1268-1275https://doi.org/10.1007/s11695-012-0662-8
        • Zambon S.
        • Romanato G.
        • Sartore G.
        • Marin R.
        • Busetto L.
        • Zanoni S.
        • et al.
        Bariatric surgery improves atherogenic LDL profile by triglyceride reduction.
        Obes Surg. 2009; 19: 190-195https://doi.org/10.1007/s11695-008-9644-2
        • Boden G.
        Obesity, insulin resistance and free fatty acids.
        Curr Opin Endocrinol Diabetes Obes. 2011; 18: 139-143https://doi.org/10.1097/MED.0b013e3283444b09
        • Benetti A.
        • Del Puppo M.
        • Crosignani A.
        • Veronelli A.
        • Masci E.
        • Frigè F.
        • et al.
        Cholesterol metabolism after bariatric surgery in grade 3 obesity: differences between malabsorptive and restrictive procedures.
        Diabetes Care. 2013; 36: 1443-1447https://doi.org/10.2337/dc12-1737
        • Woodard G.
        • Peraza J.
        • Bravo S.
        • Toplosky L.
        • Hernandez-Boussard T.
        • Morton J.
        One year improvements in cardiovascular risk factors: a comparative trial of laparoscopic Roux-en-Y gastric bypass vs. adjustable gastric banding.
        Obes Surg. 2010; 20: 578-582https://doi.org/10.1007/s11695-010-0088-0
        • Kashyap S.
        • Bhatt D.
        • Wolski K.
        • Watanabe R.
        • Abdul-Ghani M.
        • Abood B.
        • et al.
        Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 Diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment.
        Diabetes Care. 2013; 36: 2175-2182https://doi.org/10.2337/dc12-1596
        • Schauer P.
        • Kashyap S.
        • Wolski K.
        • Brethauer S.
        • Kirwan J.
        • Pothier C.
        • et al.
        Bariatric surgery versus intensive medical therapy in obese patients with diabetes.
        New Engl J Med. 2012; 366: 1567-1576https://doi.org/10.1056/NEJMoa1200225
        • Pascot A.
        • Lemieux I.
        • Prud'homme D.
        • Tremblay A.
        • Nadeau A.
        • Couillard C.
        • et al.
        Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity.
        J Lipid Res. 2001; 42: 2007-2014
        • Khan U.I.
        • Wang D.
        • Karvonen-Gutierrez C.A.
        • Khalil N.
        • Ylitalo K.R.
        • Santoro N.
        Progression from metabolically benign to at-risk obesity in perimenopausal women: a longitudinal analysis of study of women across the nation (SWAN).
        J Clin Endocrinol Metab. 2014 May 20; (jc20133259 [Epub ahead of print])
        • D'Agostino R.B.
        • Hamman R.F.
        • Karter A.J.
        • Mykkanen L.
        • Wagenknecht L.E.
        • Haffner S.M.
        Insulin resistance atherosclerosis study Investigators. Cardiovascular disease risk factors predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.
        Diabetes Care. 2004; 27: 2234-2240
        • Anderson J.W.
        • Konz E.C.
        • Frederich R.C.
        • Wood C.L.
        Long-term weight-loss maintenance: a meta-analysis of US studies.
        Am J Clin Nutr. 2001; 74: 579-584
        • Frachetti K.
        • Goldfine A.
        Bariatric surgery for diabetes management.
        Curr Opin Endocrinol Diabetes Obes. 2009; 16: 119-124https://doi.org/10.1097/MED.0b013e32832912e7
        • Schauer P.
        • Burguera B.
        • Ikramuddin S.
        • Cottam D.
        • Gourash W.
        • Hamad G.
        • et al.
        Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus.
        Ann Surg. 2003; 238: 467-485
        • Buchwald H.
        • Avidor Y.
        • Braunwald E.
        • Jensen M.D.
        • Pories W.
        • Fahrbach K.
        • et al.
        Bariatric surgery: a systematic review and meta-analysis.
        JAMA. 2004; 292: 1724-1737
        • Adams T.
        • Gress R.
        • Smith S.
        • Halverson R.
        • Simper S.
        • Rosamond W.
        • et al.
        Long-term mortality after gastric bypass surgery.
        New Engl J Med. 2007; 357: 753-761
        • Rider O.
        • Francis J.
        • Ali M.
        • Petersen S.
        • Robinson M.
        • Robson M.
        • et al.
        Beneficial cardiovascular effects of bariatric surgical and dietary weight loss in obesity.
        J Am Coll Cardiol. 2009; 54: 718-726https://doi.org/10.1016/j.jacc.2009.02.086
        • Nguyen N.T.
        • Masoomi H.
        • Magno C.P.
        • Nguyen X.M.
        • Laugenour K.
        • Lane J.
        Trends in use of bariatric surgery, 2003-2008.
        J Am Coll Surg. 2011; 213: 261-266https://doi.org/10.1016/j.jamcollsurg.2011.04.030